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Abstract
Background: Holmes tremor (HT) is an irregular, low-frequency rest tremor associated with prominent action and postural tremors. Currently, the most effective
stereotactic target and neurophysiologic characterization of HT, specifically local field potentials (LFPs) are uncertain. We present the outcome, intraoperative
neurophysiologic analysis with characterization of LFPs in a patient managed with left globus pallidus interna deep brain stimulation (Gpi DBS).
Case Report: A 24-year-old male underwent left Gpi DBS for medically refractory HT. LFPs demonstrated highest powers in the delta range in Gpi. At the 6-
month follow-up, a 90% reduction in tremor was observed.
Discussion: Pallidal DBS should be considered as an alternative target for management of refractory HT. LFP demonstrated neuronal activity associated with
higher power in the delta region, similarly seen in patients with generalized dystonia.
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Introduction
Holmes tremor (HT) is characterized by irregular, low-frequency
(,4.5 Hz) rest and prominent action and postural tremors, often
affecting proximal muscles. Also referred to as Benedick syndrome,
and rubral or midbrain tremor, HT is commonly refractory to medical
treatment with limited management options. Typically, HT is
secondary to central nervous system lesions including stroke, traumatic
brain injury, vascular malformations, multiple sclerosis, or tumors.1
It manifests as an unusual combination of low-frequency rest and
action tremor, with an associated postural component.2,3 Concurrent
dystonia, chorea, or ataxias are common.2,3
The management of HT is particularly challenging because of
limited treatment options, rarity of the disease, and the lack of large
prospective clinical studies. In single cases, responses to levodopa,
pramipexole, zonisamide, trihexyphenidyl, clonazepam, clozapine,
and levetiracetam have been reported.3,4 Nevertheless, medical
treatment is unsatisfactory in most patients and the heterogeneity of
this disorder precludes prospective treatment evaluations. Several
reports have highlighted the efficacy of thalamic ventralis intermedius
nucleus (VIM) deep brain stimulation (DBS) in HT.5–8 However, there
is no consensus regarding the best stereotactic target for HT treatment.
We identified 17 patients in the literature with HT treated with
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Table 1. Case Reports and Series of Thalamic and Subthlamic Deep Brain Stimulation in Patients with Holmes Tremor
Study
Number of Patients and
Etiology
Target Outcome Follow-up
Studies reporting VIM DBS for HT
Pahwa et al.7 Midbrain cavernous
hemangioma (symptoms
for 3 years)
Right VIM Significant improvement in








Right VIM 57% increase in dexterity and
four-point decrease in




1. Right infarct midbrain
(tremor symptoms 6 months);










Piette et al. 200414 Pontine tegmental hemorrhage Right VIM Major functional improvement 16 months
Diederich
et al.33
1. Left venous pontine angioma
(symptoms for 7 years)
2. Right midbrain hemiatrophy









Peker et al. 200815 Left thalamic abscess (symptoms
18 months)
Right VIM 90% overall improvement 2.5 years
Acar et al. 201016 Subarachnoid hemorrhage
(symptoms less than 1 month)
Bilateral VIM No tremor and reduction in


















Issar et al. 201318 1 patient with post-traumatic




Bilateral VIM Moderate partial benefit (CGI
scale 3). No TRS available
N/A
Follett et al.9 Post-traumatic HT (symptoms
for 15 years)
Bilateral VIM Reduction of tremor from a
score of 3 to a score of 1 in the
right arm and from 3.5 to 0 in




1 patient with ICH due to
cavernous malformations,
1 patient with cerebral
infarction, 1 patient with MS
1 patient with
bilateral VIM (MS
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Table 1. Continued
Study
Number of Patients and
Etiology
Target Outcome Follow-up
Studies reporting other DBS targets for HT





Almost complete resolution of
postural and intention tremors;
scored 1/4 on the WHIGET
16 months
Plaha et al. 200820 No obvious MRI abnormality
(symptoms for 6 years)
Caudal Zi 70.2% improvement in total
TRS
N/A











3. patients with cerebral
infarction, 3 patients with





















Foote et al.11 Post-traumatic tremors
3 patients with symptoms for
16 years, 3 years, 4 years
2 patients with VIM
(border VIM/Vop
and 1 with border
Voa/Vop)
Total TRS improvement of

































Kilbane et al.8 1. Right Brainstem hemorrhage
due to cavernous malformation
2. Left thalamic midbrain
bullet fragment
Patient 1 had VIM/
Voa and Gpi leads.
Patient 2 had
VIM/Gpi leads
77.5% improvement in TRS.
VIM or combined stimulation





Abbreviations: Gpi, Globus Pallidus Interna; ICH, Intracranial Hemorrhage; MS, Multiple Sclerosis; MRI, Magnetic Resonance Imaging; PSA, Posterior Subthalamic
Area; STN, Subthalamic Nucleus; TETRAS, The Essential Tremor Rating Assessment Scale; TRS, Tremor Rating Scale; VIM, Ventral Intermedius Nucleus;
Voa, Ventralis Oralis Anterior Nucleus; Vop, Ventralis Oralis Posterior Nucleus; VO, ventralis oralis; WHIGET, Washington HeightsInwood Genetic
Study of Essential Tremor; Zi, Zona Incerta; AVM, arteriovenous malformation
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contralateral VIM DBS, 11 patients treated with globus pallidus
interna (GPi) DBS, four patients treated with dual-lead stimulation in
the VIM and posterior subthalamic area (PSA), and three patients
treated with dual leads located at the border of VIM/ventralis oralis
posterior nucleus (Vop) and ventralis oralis anterior nucleus (Voa)/
Vop, three patients treated with VIM DBS with the deepest contact
located in the PSA, and individual cases of stimulation of the Voa and
zona incerta (Zi), VIM and subthalamic nucleus (STN), lenticular
fasciculus, and caudal Zi5–11 (Table 1). Although the outcome scales
and follow-up varied among studies, the average overall improvement
in tremor was 76% with an average age of 41 years (range
11–84 years), HT duration of 6 years (range 6 months to 32 years),
Figure 1. Axial (left) and sagittal (middle) T1 weighted MRI with gadolinium, and sagittal CT scan (right) of unsecured AV fistula.
Figure 2. Sample LFP spectrograms in GPI (action) (A) and GPE (B). Corresponding GPI (C) and GPE (D) power spectral densities are
included. Brackets (A-D): D, delta (0–3Hz); h, theta (4-7 Hz); a, alpha (8–12Hz); Lb, low beta (13–20Hz); Hb, high beta (21–29Hz); c, gamma
(30-200Hz). Mean PSD values (¡ SEM) for each spectral band for GPI (action) (E), GPI (rest) (F) and GPE (G) are shown.
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and an average follow-up of 3 years (range 6 months to 12 years). Dual
thalamic stimulation, such as VIM with Voa/Vop or with PSA, was
shown to offer significant improvements as it was proposed to override
a hypothesized abnormality in both the pallido-thalamic and the
cerebello-thalamic circuits.11,22 More recently, GPi DBS has been
proposed as a potential target in small case series. An overall
improvement of 64% and 78% in tremor scales was observed, and
in a few exceptional cases there was complete tremor resolution.8
Owing to the diverse and variable injuries causing HT disrupting
the basal ganglia or thalamic anatomy, careful selection of stimulation
target for each patient is required. Kilbane et al.8 reported four
patients managed with unilateral Gpi DBS with adequate and
persistent tremor control long term, with a mean follow-up of 3 years.
Similarly, Espinoza-Martinez et al.5 reported encouraging results with
an average follow-up of 5 years in seven patients treated with Gpi DBS
for HT. The pathophysiology of HT is complex with only scarce data
regarding the neurophysiological characteristics of the disease. Kilbane
et al.8 reported their analysis of single unit neuronal activity (SUA) in
HT. They found mean firing rates in HT patients at rest (56.2¡28.5
Hz) and action (53.5¡19.4 Hz) to be much lower than Gpi recordings
in Parkinson’s disease (PD) patients.8 In this report, we present the
clinical outcome of a patient treated with left Gpi DBS for HT due to
midbrain injury secondary to ruptured arteriovenous (AV) fistula along
with intraoperative neurophysiologic data. To the best of our
knowledge, we are the first to report LFP data from a patient with
HT adding to the understanding of neurophysiology in this rare
condition.
Case report
The patient is a 24-year-old male who suffered a pontine and
midbrain hemorrhage secondary to rupture of AV fistula at age 17. In
addition, a large varix was found in the vein of the Galen and
brainstem in the setting of a complex AV fistula. An embolization of
the fistula was attempted, partially reducing the size of the fistula. The
anatomy of the vascular malformation precluded further treatment.
After discharge from rehabilitation, he had mild cognitive deficits,
severe ataxia, oculomotor difficulties, spastic dysarthria, and right arm
clumsiness. Associated hand dystonia with finger and wrist flexion was
present as well. Over the following 6 months, the patient noted
insidious onset of progressive right arm low-frequency resting,
postural, and action tremor diagnostic of HT. The symptoms initially
worsened, with the development of right leg and palatal tremor.
Multiple medical treatments were attempted including botulinum
toxin injections (250 units), levetiracetam (3000 mg/day), carbidopa/
levodopa (900 mg/day), trihexyphenidyl (6 mg/day), baclofen (40 mg/
day), and propranolol (120 mg/day) with no benefit in tremor and
intolerable side effects, namely sedation or cognitive difficulties.
Tremor affected proximal muscles and rendered his right hand non-
functional. After careful consideration of the surgical risks, DBS was
considered. A pre-surgical computed tomography angiogram and
brain magnetic resonance imaging (Figure 1) demonstrated a complex
brain AV malformation with preserved pallidal anatomy. There was
no evidence of parenchymal injury but a large varicose vein in the
posterior circulation, thalamocapsular arteries territory, and mesence-
phalon was noted. The risks and benefits of the procedure were
discussed at length and at multiple settings with both the patient, who
was fully competent, and his mother. The treating neurosurgeon for
the AV fistula provided preoperative clearance.
We opted to perform a single procedure with lead and battery
placement the same day to minimize anesthetic risk. Blood pressure
was closely regulated during the procedure, and was monitored using
an arterial line until the next morning. He was discharged home on
postoperative day 1 with no complications. The tremor severity was
evaluated using the lateralized (right) Fahn–Tolosa–Marin Tremor
Rating Scale (TRS). His preoperative score was 40. One month after
the operation during monopolar review of the DBS electrodes, acute
improvement in the tremor was noted. The tremor and limb dystonia
improved with sustained benefit over the following 6 months. The
Figure 3. Paired t-test of GPI firing frequency at rest vs. action (A) and GPI bursting index at rest vs. action (B).
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amplitude and pulse width were adjusted to maximize benefit.
Interestingly, the patient also noted improvement in tongue and
palatal tremor with unilateral stimulation. Programming settings were
unipolar mode, case positive, contact 1 negative, pulse width 90 ms,
and frequency 180 Hz. During programming, reversible corticospinal
side effects at high amplitudes leading to dysarthria and facial tonic
contractions were the most commonly reported side effect. At the
6-month follow-up, he was able to draw, color books, dress, and drink
from a cup using one hand. Elements of cerebellar ataxia remained
unchanged with otherwise normal muscle tone, strength, and
resolution of dystonic postures. His TRS right hand score improved
to a total score of 8, which represents an 80% overall improvement.
LFP and single unit (SU) recordings were obtained using
microelectrodes during surgery in the Gpi and globus pallidus externa
(Gpe) based on characteristic firing patterns.23 LFPs were monitored
using the Guideline 4000 LP Neuromodulation System (Frederick C.
Haer, Bowdoin, ME), and recorded using glass-coated platinum/
iridium microelectrode electrodes (0.4–1.0 mV). SUA signals were
filtered (high pass 500 Hz and low pass 5 kHz), amplified, and digitized
(48,000 Hz sampling frequency). SUAs were obtained at rest and
during active movement (elbow flexion/extension). LFPs were filtered
at 1000 Hz.
LFP analyses and spectrograms were generated from 0 to 50 Hz
using a fast Fourier transform in NeuroExplorer (Nex Technologies,
Madison, AL). The spectrogram was normalized so that the sum of all
the spectrum values equaled the mean squared value of the signal and
no overlap was used. Power spectral density (PSD) analyses were done
on 10 seconds of trace with a 50 Hz cut-off. Bands were separated into
delta (,4 Hz), theta (4–7 Hz), alpha (8–12 Hz), low beta (13–20 Hz),
and high beta (21–29 Hz) bins for separate PSD analyses. Data were
processed in Matlab to generate values for each band. Graphpad
Prism was used to generate average band values among all
microelectrode recordings. SU activity with a 2:1 signal-to-noise ratio
was analyzed using principal component analysis using the Plexon
offline sorter and quantified using NeuroExplorer. An analysis of
interspike intervals in Neuroexplorer used to evaluate the stationarity
of discharge and then exported into Matlab for processing was used to
obtain the bursting index.
LFP recordings revealed highest powers in delta and theta followed
by a decrease in power with each subsequent frequency after (alpha,
beta, and gamma) with action (Figure 2). Beta frequencies had
significantly more power than gamma in the Gpi (p50.0067)
(Figure 2). At rest, the LFP recording showed delta to be much lower
than subsequent bands (theta, alpha, beta). The resting state Gpi
LFP alpha-beta spectral peak was found to be at 12 Hz. In the Gpe,
high delta and higher low beta frequencies were appreciated.
Microelectrode recording (MER) were obtained in the Gpi and Gpe
to study neuronal firing rates and bursting indices (BIs) (Figure 3). The
mean firing rate in the Gpi at rest was 70.57¡25.87 Hz (n57 cells);
with action it was 59.52¡8.84 Hz (n57 cells), and 31.33 Hz (n51 cell)
in the Gpe at rest. There was no significant difference in firing
frequency in the Gpi during rest and action (p50.69). Furthermore, no
changes were found in the Gpi BI rest (4.55¡0.93) action (5.58¡0.84)
(p50.28, Figure 3). In the Gpe at rest, the BI was 7.46 (n51).
Discussion
We present the outcome and neurophysiological findings in a HT
patient treated with Gpi DBS. Our patient is unique as it is the first
reported DBS surgery performed on a patient with HT having a
partially treated significant vascular lesion and because of the
assessment of electrophysiological data and analysis of Gpi LFP.
Patients facing such challenges require specialized care and treat-
ment.24 Collaborating with other specialties is critical, as exemplified
in this case with the need of collaboration between a vascular
neurosurgeon and an experienced anesthesia team.
The optimal target for treating HT remains a subject of debate,
although most case series and case reports have shown positive short-
term results with a variety of stimulation targets. Although thalamic
VIM has been traditionally considered the main target for refractory
tremors, our case adds to the increasing body of literature
demonstrating marked tremor benefit with pallidal stimulation in
patients with HT. At the present time, stereotactic target selection in
HT cases should be based on associated clinical features and surgical
neuroanatomy. Gpi DBS should be particularly considered in cases
where the VIM nucleus anatomy is grossly disrupted by intracranial
pathology (affecting stereotactic planning and theoretically affecting
cerebello-thalamic-cortical loop effects of DBS), when intraoperative
tremor control is unsatisfactory despite VIM high-intensity stimulation
and in patients with associated movement disorders such as chorea,
parkinsonism, and dystonia.
The pathophysiological mechanisms underlying HT remain incom-
pletely understood; however, abnormal synchronization of basal
ganglia activity is suggested to underlie many movement disorders.
We are the first to report LFP data from a patient with HT, adding to
the understanding of this syndrome. We observed high power at low
frequencies in the delta and theta regions with action (,3.5 Hz) in
LFPs, a range consistently associated with hyperkinesias.25 For
example, PD patients on high dosages of levodopa with dyskinesias
show increased delta activity, whereas PD patients experiencing
bradykinesia or rigidity have low delta activity.26 Higher power in the
delta region of our patient is thus likely associated with hyperkinetic
movements and tremor observed in our patient. There was higher beta
activity relative to lower gamma power, similar to findings in PD.27,28
In a non-human primate model of PD, high power was seen in the late
alpha and low-beta regions (7.8–15.5 Hz), and low power was seen in
the late high-beta and early gamma regions (23.4–35.1 Hz).29 These
changes in power were significantly correlated with PD motor scores.29
However, unlike in PD, our HT case presented an overall decrease in
oscillatory activity upon approaching higher frequency values,
producing a downward slope, with the greatest activity at delta and
the lowest at gamma. Because PD patients exhibit low delta activity,
recordings show a wave with the greatest activity peaking in the beta
regions.26 This difference showing the delta region as most active for
HT, versus the beta region as most active in PD, can explain the
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differences associated with motor pathophysiology, with greater
hyperkinetic movements and less rigidity seen in HT than in PD.
Spectral analysis of HT therefore more resembles dystonia than PD.
Dystonia has been shown to have very low power in the beta range,
associated with diminished bradykinesia and Parkinson’s rigidity.28 In
addition, similar to our findings, it has been shown to have higher
power in the delta and alpha regions than in PD and is similarly
associated with hyperkinesia and dyskinesia.30,31 Although there was
some beta activity present in our case, it was not prominent relative to
the high delta and theta activity. Also, beta activity can vary
substantially over small distances relative to electrode placement and
therefore can decrease the correlation between motor movements and
beta activity.32
SUA in our patient showed firing rates similar to other cases of HT
in the literature.33 Kilbane et al.8 reported their mean firing rate for
HT to be 56.2¡28.5 Hz at rest, and 63.5¡28.5 Hz with action. Our
mean firing rate at rest was slightly higher, but as both had large
standard errors of the mean (SEMs), they fell in the range of one
another. In addition, our case reported a similar firing rate with action,
suggesting our patient exhibited far lower firing during voluntary
movement than the PD cohort, as concluded in Kilbane et al.8
Increased firing rates are associated with PD but lower firing rates
occur during hyperkinetic disorders, such as generalized dystonia and
Tourette syndrome.23,34,35 The mean BI at rest in this study was found
to be higher than in a study comparing both dystonia and PD.23 In a
previous report, 22 dystonia patients, and 11 PD patients were found
to have on average a higher BI (3.7¡0.1) in dystonia than in PD
(2.2¡0.1).23 Although the BI was higher in our patient, the dystonia
BI fell in the range of the SEM of our patient’s BI, suggesting our BI
resembles that more closely associated with dystonia. In addition, the
higher BI average may be due to differences in the methodology and
limitations of our study. Starr et al.23 reported a cohort of 22 patients
providing a large sample of Gpi cells; however, due to high neuronal
density and challenge in isolating single units, our BI at rest involved
only seven cells from one patient. Additionally, HT patients in the
Kilbane et al. report also exhibited higher BIs than that of the PD
cohort, suggesting our SUA findings to be similar to the literature.
Overall, these outcomes further support the pathophysiology of HT as a
non-parkinsonian disorder. Elevated firing rates seen in PD are expected
with high basal ganglia outputs associated with nigrostriatal denerva-
tion.8 Instead, the lower firing rate seen in our HT case is in agreement
with the current literature that HT is involved with thalamostriate
connections between basal ganglia and cerebellar pathways.8,36
In conclusion, pallidal DBS should be considered as an alternative
target for management of refractory HT as available data support
remarkable tremor control regardless of the HT etiology. LFPs
demonstrated neuronal activity associated with higher power in the
delta region, similar to changes observed in patients with generalized
dystonia. SUAs from our patient showed firing rates lower than
that in PD but with a bursting index higher than both PD and
dystonia.
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